Proof of concept of intracochlear drug administration by laser-assisted bioprinting in mice

[1]  Sophie S. Liu,et al.  Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities , 2022, Frontiers in Neuroscience.

[2]  R. Devillard,et al.  In vitro and in vivo characterization of a novel tricalcium silicate-based ink for bone regeneration using laser-assisted bioprinting , 2022, Biofabrication.

[3]  S. Pietropaolo,et al.  Synaptic Release Potentiation at Aging Auditory Ribbon Synapses , 2020, bioRxiv.

[4]  David M. Kelley,et al.  Clinical Practice Guideline: Sudden Hearing Loss (Update) , 2019, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[5]  L. Rybak,et al.  Local Drug Delivery for Prevention of Hearing Loss , 2019, Front. Cell. Neurosci..

[6]  M. Rémy,et al.  In situ prevascularization designed by laser-assisted bioprinting: effect on bone regeneration , 2019, Biofabrication.

[7]  F. Piu,et al.  Local Drug Delivery for the Treatment of Neurotology Disorders , 2019, Front. Cell. Neurosci..

[8]  P. Steyger,et al.  Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier , 2019, Science Translational Medicine.

[9]  Lisheng Yu,et al.  A comparison of systemic and local dexamethasone administration: From perilymph/cochlea concentration to cochlear distribution , 2018, Hearing Research.

[10]  A. Salt,et al.  Dexamethasone and Dexamethasone Phosphate Entry into Perilymph Compared for Middle Ear Applications in Guinea Pigs , 2018, Audiology and Neurotology.

[11]  A. Salt,et al.  Permeation Enhancers for Intratympanically-applied Drugs Studied Using Fluorescent Dexamethasone as a Marker. , 2018, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[12]  J. Carey,et al.  Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial , 2016, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[13]  E. Begg,et al.  Intratympanic Versus Intravenous Delivery of Dexamethasone and Dexamethasone Sodium Phosphate to Cochlear Perilymph , 2011, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[14]  F. Piu,et al.  OTO-104: A Sustained-Release Dexamethasone Hydrogel for the Treatment of Otic Disorders , 2011, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[15]  A. Salt,et al.  Distribution of Dexamethasone and Preservation of Inner Ear Function following Intratympanic Delivery of a Gel-Based Formulation , 2010, Audiology and Neurotology.

[16]  Jeffrey T Borenstein,et al.  Inner ear drug delivery for auditory applications. , 2008, Advanced drug delivery reviews.

[17]  J. Bale,et al.  Sensorineural hearing loss in children , 2005, The Lancet.

[18]  Justin Tan,et al.  Adjuvant agents enhance round window membrane permeability to dexamethasone and modulate basal to apical cochlear gradients , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  F. Guillemot,et al.  Cell patterning by laser-assisted bioprinting. , 2014, Methods in cell biology.